The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina

Anoka A. Njan, Bulus Adzu, Amon G. Agaba, Dominic Byarugaba, Silvia Díaz-Llera, David Bangsberg

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Vernonia amygdalina possesses several bioactive compounds and is used in traditional medicines of southwestern Uganda, along with other regions. Its analgesic potential has not been investigated thus far. The present study examines the antinociceptive potential of the aqueous leaf extract (50-200 mg/kg) using three models of nociception (acetic acid-induced writhing, formalin test, and tail-flick test), antiplasmodial activity, and toxicology of the extract. The results show the extract significantly inhibits acetic acid-induced writhing and the formalin test in mice but did not give a potent effect in the tail-flick test, suggesting that the extract may have peripheral and central analgesic properties. The extract also exhibited significant antiplasmodial activity in mice against Plasmodium berghei with 73% inhibition in the group that received a dose of 200 mg/kg i.p. daily for 4 days. Toxicology results show no clinical signs of toxicity or adverse toxicological effects in the treated groups, except for a significant decrease in red blood cell count and a dose-dependent increase in serum bilirubin. These changes were within control values based on historical reference ranges at doses of 500-2,000 mg/kg/day for 14 consecutive days as compared to the control. This study supports the traditional use of V. amygdalina as an alternative therapy for malaria and the symptomatic relief of pain usually associated with malaria.

Original languageEnglish (US)
Pages (from-to)574-581
Number of pages8
JournalJournal of Medicinal Food
Volume11
Issue number3
DOIs
StatePublished - Sep 1 2008
Externally publishedYes

Fingerprint

Vernonia
Toxicology
Analgesics
Pain Measurement
Acetic Acid
Malaria
Tail
Plasmodium berghei
Erythrocyte Count
Nociception
Uganda
Traditional Medicine
Complementary Therapies
Bilirubin
Reference Values
Pain
Serum

Keywords

  • Malaria
  • Pain
  • Toxicity
  • Traditional medicine
  • Uganda

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina. / Njan, Anoka A.; Adzu, Bulus; Agaba, Amon G.; Byarugaba, Dominic; Díaz-Llera, Silvia; Bangsberg, David.

In: Journal of Medicinal Food, Vol. 11, No. 3, 01.09.2008, p. 574-581.

Research output: Contribution to journalArticle

Njan, Anoka A. ; Adzu, Bulus ; Agaba, Amon G. ; Byarugaba, Dominic ; Díaz-Llera, Silvia ; Bangsberg, David. / The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina. In: Journal of Medicinal Food. 2008 ; Vol. 11, No. 3. pp. 574-581.
@article{7b5f22a24e7b44368845606c3ecba788,
title = "The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina",
abstract = "Vernonia amygdalina possesses several bioactive compounds and is used in traditional medicines of southwestern Uganda, along with other regions. Its analgesic potential has not been investigated thus far. The present study examines the antinociceptive potential of the aqueous leaf extract (50-200 mg/kg) using three models of nociception (acetic acid-induced writhing, formalin test, and tail-flick test), antiplasmodial activity, and toxicology of the extract. The results show the extract significantly inhibits acetic acid-induced writhing and the formalin test in mice but did not give a potent effect in the tail-flick test, suggesting that the extract may have peripheral and central analgesic properties. The extract also exhibited significant antiplasmodial activity in mice against Plasmodium berghei with 73{\%} inhibition in the group that received a dose of 200 mg/kg i.p. daily for 4 days. Toxicology results show no clinical signs of toxicity or adverse toxicological effects in the treated groups, except for a significant decrease in red blood cell count and a dose-dependent increase in serum bilirubin. These changes were within control values based on historical reference ranges at doses of 500-2,000 mg/kg/day for 14 consecutive days as compared to the control. This study supports the traditional use of V. amygdalina as an alternative therapy for malaria and the symptomatic relief of pain usually associated with malaria.",
keywords = "Malaria, Pain, Toxicity, Traditional medicine, Uganda",
author = "Njan, {Anoka A.} and Bulus Adzu and Agaba, {Amon G.} and Dominic Byarugaba and Silvia D{\'i}az-Llera and David Bangsberg",
year = "2008",
month = "9",
day = "1",
doi = "10.1089/jmf.2007.0511",
language = "English (US)",
volume = "11",
pages = "574--581",
journal = "Journal of Medicinal Food",
issn = "1096-620X",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina

AU - Njan, Anoka A.

AU - Adzu, Bulus

AU - Agaba, Amon G.

AU - Byarugaba, Dominic

AU - Díaz-Llera, Silvia

AU - Bangsberg, David

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Vernonia amygdalina possesses several bioactive compounds and is used in traditional medicines of southwestern Uganda, along with other regions. Its analgesic potential has not been investigated thus far. The present study examines the antinociceptive potential of the aqueous leaf extract (50-200 mg/kg) using three models of nociception (acetic acid-induced writhing, formalin test, and tail-flick test), antiplasmodial activity, and toxicology of the extract. The results show the extract significantly inhibits acetic acid-induced writhing and the formalin test in mice but did not give a potent effect in the tail-flick test, suggesting that the extract may have peripheral and central analgesic properties. The extract also exhibited significant antiplasmodial activity in mice against Plasmodium berghei with 73% inhibition in the group that received a dose of 200 mg/kg i.p. daily for 4 days. Toxicology results show no clinical signs of toxicity or adverse toxicological effects in the treated groups, except for a significant decrease in red blood cell count and a dose-dependent increase in serum bilirubin. These changes were within control values based on historical reference ranges at doses of 500-2,000 mg/kg/day for 14 consecutive days as compared to the control. This study supports the traditional use of V. amygdalina as an alternative therapy for malaria and the symptomatic relief of pain usually associated with malaria.

AB - Vernonia amygdalina possesses several bioactive compounds and is used in traditional medicines of southwestern Uganda, along with other regions. Its analgesic potential has not been investigated thus far. The present study examines the antinociceptive potential of the aqueous leaf extract (50-200 mg/kg) using three models of nociception (acetic acid-induced writhing, formalin test, and tail-flick test), antiplasmodial activity, and toxicology of the extract. The results show the extract significantly inhibits acetic acid-induced writhing and the formalin test in mice but did not give a potent effect in the tail-flick test, suggesting that the extract may have peripheral and central analgesic properties. The extract also exhibited significant antiplasmodial activity in mice against Plasmodium berghei with 73% inhibition in the group that received a dose of 200 mg/kg i.p. daily for 4 days. Toxicology results show no clinical signs of toxicity or adverse toxicological effects in the treated groups, except for a significant decrease in red blood cell count and a dose-dependent increase in serum bilirubin. These changes were within control values based on historical reference ranges at doses of 500-2,000 mg/kg/day for 14 consecutive days as compared to the control. This study supports the traditional use of V. amygdalina as an alternative therapy for malaria and the symptomatic relief of pain usually associated with malaria.

KW - Malaria

KW - Pain

KW - Toxicity

KW - Traditional medicine

KW - Uganda

UR - http://www.scopus.com/inward/record.url?scp=52149085960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52149085960&partnerID=8YFLogxK

U2 - 10.1089/jmf.2007.0511

DO - 10.1089/jmf.2007.0511

M3 - Article

C2 - 18800909

AN - SCOPUS:52149085960

VL - 11

SP - 574

EP - 581

JO - Journal of Medicinal Food

JF - Journal of Medicinal Food

SN - 1096-620X

IS - 3

ER -